Medsafe has granted provisional approval for the Pfizer COVID-19 vaccine for children aged 5 to 11 years old. Medsafe Group Manager, Chris James, says the Pfizer COVID-19 vaccine for this age group is an adapted version of the vaccine used for people aged 12 and older.
The provisional approval is for two doses of the paediatric Pfizer COVID-19 vaccine, given at least 21 days apart. “The Medsafe team has worked tirelessly this year to ensure that COVID-19 vaccine applications are prioritised and urgently reviewed, while still maintaining the same scrutiny that all medicine applications undergo before they can be approved. “Medsafe will only approve a vaccine or medicine for use in New Zealand once it is satisfied that it has met high